Abstract
To identify robust circulating predictors for incident atrial fibrillation (AF) using classical regressions and machine learning (ML) techniques within a broad spectrum of candidate variables. In pooled European community cohorts (n = 42 280 individuals), 14 routinely available biomarkers mirroring distinct pathophysiological pathways including lipids, inflammation, renal, and myocardium-specific markers (N-terminal pro B-type natriuretic peptide [NT-proBNP], high-sensitivity troponin I [hsTnI]) were examined in relation to incident AF using Cox regressions and distinct ML methods. Of 42 280 individuals (21 843 women [51.7%]; median [interquartile range, IQR] age, 52.2 [42.7, 62.0] years), 1496 (3.5%) developed AF during a median follow-up time of 5.7 years. In multivariable-adjusted Cox-regression analysis, NT-proBNP was the strongest circulating predictor of incident AF [hazard ratio (HR) per standard deviation (SD), 1.93 (95% CI, 1.82–2.04); P < 0.001]. Further, hsTnI [HR per SD, 1.18 (95% CI, 1.13–1.22); P < 0.001], cystatin C [HR per SD, 1.16 (95% CI, 1.10–1.23); P < 0.001], and C-reactive protein [HR per SD, 1.08 (95% CI, 1.02–1.14); P = 0.012] correlated positively with incident AF. Applying various ML techniques, a high inter-method consistency of selected candidate variables was observed. NT-proBNP was identified as the blood-based marker with the highest predictive value for incident AF. Relevant clinical predictors were age, the use of antihypertensive medication, and body mass index. Using different variable selection procedures including ML methods, NT-proBNP consistently remained the strongest blood-based predictor of incident AF and ranked before classical cardiovascular risk factors. The clinical benefit of these findings for identifying at-risk individuals for targeted AF screening needs to be elucidated and tested prospectively. AMDMS, Averaged minimal depth of a maximal subtree; BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density lipoprotein; HF, heart failure; LASSO, Least absolute shrinkage and selection operator; LDL, low-density lipoprotein; LOD, limit of detection; MI, myocardial infarction; NT-proBNP, N-terminal pro B-type natriuretic peptide; RSF, Random survival forest; VIMP, variable importance.
Funding Information
  • European Research Council
  • European Union’s Horizon 2020 (648131, 847770)
  • German Center for Cardiovascular Research (81Z1710103, 81Z0710114)
  • German Ministry of Research and Education (01ZX1408A, 031L0239, BMH4-CT98-3183, QLG2-CT-2002-01254, HEALTH-F4-2007-201413, HEALTH-F3-2010-242244, HEALTH-F2-2011-278913, 825903)
  • Medical Research Council, London (G0601463, 80983)
  • MORGAM Data Centre
  • MORGAM Laboratories
  • MORGAM Participating Centres
  • National Institute for Health and Welfare
  • Finnish Foundation for Cardiovascular Research
  • Emil Aaltonen Foundation
  • Research Council of Finland (321351, European Union)
  • Swedish Heart and Lung Foundation
  • Ministero della Salute

This publication has 17 references indexed in Scilit: